Themis Medicare Ltd had received a letter dated 11th July, 2018 from the Food and Drug Administration (FDA) authorities directing, not to manufacture a key product till deciding of the matter. The Company, being aggrieved by the developments, had filed a Writ Petition in the Hon'ble Delhi High Court in this connection and the same was admitted by the Hon'ble Delhi High Court.
However, the Hon'ble Delhi High Court vide its order dated July 5, 2018 has dismissed the Company's petition.
Meanwhile, since the Court has uploaded a copy of the same on its website, the Company is hereby making the disclosure. Also the Company has applied for a certified copy of the order and the same is awaited.
The Company believes it has a strong case and intends to file an appeal against the said order in consultation with its lawyers.
Shares of THEMIS MEDICARE LTD. was last trading in BSE at Rs.208.75 as compared to the previous close of Rs. 205.2. The total number of shares traded during the day was 12 in over 4 trades.
The stock hit an intraday high of Rs. 222.95 and intraday low of 205. The net turnover during the day was Rs. 2569.